Patents by Inventor Subash Chandra Verma

Subash Chandra Verma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the isolation of oleane compounds isolated from the bark of arjun tree terminalia arjuna (Roxb.)
    Patent number: 7435433
    Abstract: The present invention provides an improved process for the isolation of oleane compounds from the bark of Terminalia arjuna (Roxb.). More particularly, the present invention relates to an improved process for the isolation of arjunic acid and its derivates from the bark of Terminalia arjuna (Roxb.). The present invention further provides the identification of arjunic acid [1] and its derivatives as anticancer agent useful in the treatment of various types of cancer in humans.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: October 14, 2008
    Assignee: Council of Scientific & Industrial Research
    Inventors: Suman Preet Singh Khanuja, Madan Mohan Gupta, Santosh Kumar Srivastava, Tiruppadiripuliyur Ranganathan Santha Kumar, Digvijay Singh, Subash Chandra Verma, Ankur Grag, Merajuddin Khan, Ram Kishor Verma, Raghavendra Kumar Mishra, Subash Chandra Singh
  • Nitrile glycoside useful as a bioenhancer of drugs and nutrients, process of its isolation from moringa oleifera
    Patent number: 6858588
    Abstract: The present invention relates to a novel nitrile glycoside of Formula I named NIAZIRIDIN and to analogues and derivatives thereof. The present invention also relates to a process for the isolation of a novel nitrile glycoside of Formula I below named NIAZIRIDIN and its derivatives and analogues by bioactivity-guided fractionation from the pods of Moringa oleifera. The present invention particularly relates to the bioenhancing activity of the novel nitrile glycoside of Formula I below named NIAZIRIDIN and its derivatives and analogues in enhancing bioactivity of commonly used antibiotics such as rifampicin, tetracycline and ampicillin against Gram (+) and (?) bacteria. The biomolecule also enhances the absorption of drugs, vitamins and nutrients through the gastro-intestinal membrane increasing their bio-availability. Therefore niaziridin can be used in combination therapy with drugs and nutrients resulting in reduced drug associated toxicity, reduced cost and duration of chemotherapy.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: February 22, 2005
    Assignee: Council of Scientific and Industrial Research
    Inventors: Suman Preet Singh Khanuja, Jai Shanker Arya, Ranganathan Santha Kumar Tiruppadiripuliyur, Dharmendra Saikia, Harpreet Kaur, Monika Singh, Subhash Chandra Gupta, Ajit Kumar Shasany, Mahendra Pandurang Darokar, Santosh Kumar Srivastava, Madan Mohan Gupta, Subash Chandra Verma, Anirban Pal
  • Antimicrobial and anticancer properties of methyl-beta-orcinolcarboxylate from lichen (Everniastrum cirrhatum)
    Publication number: 20040198815
    Abstract: The present invention relates to the new use of an already known biomolecule methyl-&bgr;-orcinol carboxylate of formula 1 isolated from a lichen (Everniastrum cirrhatum), for treating pathogenic fungal infections of humans that are resistant to polyene and azole antibiotics such as amphotericin B, nystatin, clotrimazole etc.
    Type: Application
    Filed: March 31, 2003
    Publication date: October 7, 2004
    Applicant: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
    Inventors: Suman Preet Singh Khanuja, Ranganathan Santha Kumar Tiruppadiripuliyur, Vivek Kumar Gupta, Preeti Chand, Ankur Garg, Santosh Kumar Srivastava, Subash Chandra Verma, Dharmendra Saikia, Mahendra Pandurang Darokar, Ajit Kumar Shasany, Anirban Pal
  • NOVEL NITRILE GLYCOSIDE USEFUL AS A BIOENHANCER OF DRUGS AND NUTRIENTS, PROCESS OF ITS ISOLATION FROM MORINGA OLEIFERA
    Publication number: 20040198669
    Abstract: The present invention relates to a novel nitrile glycoside of Formula I named NIAZIRIDIN and to analogues and derivatives thereof. The present invention also relates to a process for the isolation of a novel nitrile glycoside of Formula I below named NIAZIRIDIN and its derivatives and analogues by bioactivity-guided fractionation from the pods of Moringa oleifera. The present invention particularly relates to the bioenhancing activity of the novel nitrile glycoside of Formula I below named NIAZIRIDIN and its derivatives and analogues in enhancing bioactivity of commonly used antibiotics such as rifampicin, tetracycline and ampicillin against Gram (+) and (−) bacteria. The biomolecule also enhances the absorption of drugs, vitamins and nutrients through the gastro-intestinal membrane increasing their bio-availability. Therefore niaziridin can be used in combination therapy with drugs and nutrients resulting in reduced drug associated toxicity, reduced cost and duration of chemotherapy.
    Type: Application
    Filed: March 31, 2003
    Publication date: October 7, 2004
    Applicant: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
    Inventors: Suman Preet Singh Khanuja, Jai Shanker Arya, Ranganathan Santha Kumar Tiruppadiripuliyur, Dharmendra Saikia, Harpreet Kaur, Monika Singh, Subhash Chandra Gupta, Ajit Kumar Shasany, Mahendra Pandurang Darokar, Santosh Kumar Srivastava, Madan Mohan Gupta, Subash Chandra Verma, Anirban Pal